THE DEAL, AT A GLANCE
1/4 reviewedL-Nutra
L-Nutra
L-Nutra makes clinically tested nutrition programs for longevity and chronic disease medical nutrition.
L-Nutra raised $84M Series D, announced 2026-09-2401What it doesL-Nutra makes clinically tested nutrition programs for longevity and chronic disease medical nutrition.Source-grounded · automated review · Explore ↗
Checked 2026-10-04 · Review due 2026-10-11
Read supporting source ↗L-Nutra's programs — including Prolon…
02Who is involvedBacked by MubadalaFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedL-Nutra raised $84M Series D, announced 2026-09-24From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersL-Nutra’s $84M Series D from Mubadala supports a scale-up thesis for a longevity nutrition company at a later private financing stage.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. The image is supplied by the cited source.Original record source ↗
L-Nutra · Financing Record
Explore source-linked visual explanations for L-Nutra. Unsupported claims are withheld while source review continues.
Record 12698 · Recorded date: 2026-09-24
Explore company records →